Annovis secures FDA agreement on safety plan ahead of buntanetap NDA
ANVS•Annovis Bio said it secured FDA agreement on an integrated safety summary combining Alzheimer’s and Parkinson’s data and plans to submit a buntanetap NDA after the DUET-AD data readout.
1. FDA safety plan
Annovis Bio secured FDA agreement on an integrated summary of safety data combining Alzheimer’s and Parkinson’s data ahead of a planned buntanetap NDA. The company said it will submit the application after the DUET-AD data readout.




